Health TrialsbyHealthPanel

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

ConditionsPulmonary HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-100
SponsorChinese Pulmonary Vascular Disease Research Group

About this trial

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

pulmonary arterial hypertension;( WHO1)

chronic thromboembolic pulmonary hypertension;

pulmonary arterial hypertension due to other cause;

Disqualifiers

massive hemoptysis;

unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;

recent recurrent syncope;

pulmonary hypertension due to hypoxia;

Trial population

pulmonary hypertension who may accomplish cardiopulmonary exercise testing.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • balloon pulmonary angioplasty

    Device

    patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty

Treatment groups

4,000 Participants
are divided into 1 treatment group
Group A: cardiopulmonary exercise testing1 intervention

Trial outcomes

Primary outcomes

1

all cause mortality

all cause mortality

Time frame
5 years
2

mean pulmonary arterial pressure after treatment

the mean pulmonary arterial pressure of patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty treatment

Time frame
5 years
3

achievement of low risk

patients with chronic thromboembolic pulmonary hypertension achievement of low risk after balloon pulmonary angioplasty

Time frame
5 years

Secondary outcomes

1

deterioration of WHO function

deterioration of WHO function

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chinese Pulmonary Vascular Disease Research Group

Lead sponsor

Source ClinicalTrials.gov
Apply now